Clinical Trial Update: BioFreedom US IDE Feasibility Trial [Phase 2, Phase 3]

View source ↗

Summary

Update on the BioFreedom US IDE feasibility trial conducted across Phase 2 and Phase 3 for ischemic heart disease and related angina conditions; the current tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease
• Silent Ischemia
• Stable Angina
• Unstable Angina

Drugs mentioned

• BioFreedom

Snippet

Sponsor: Biosensors Europe SA | Conditions: Ischemic Heart Disease, Stable Angina | Phase 2, Phase 3 | Status: UNKNOWN